Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422511 · ClinicalTrials.gov registry record · NA
Genomic Sequencing for Childhood Risk and Newborn Illness
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,205
- Enrollment target
NCT02422511 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 1,205 participants.
The verdict
NCT02422511, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,205 participants
- Enrollment target
Study Summary
The Genomic Sequencing for Childhood Risk and Newborn Illness (the BabySeq Project) is a research study exploring the use of genomic sequencing in newborns. The National Institutes of Health is funding this study. The investigators will enroll 240 healthy infants and their parents from the Brigham and Women's Hospital (BWH) Well Newborn Nursery and 240 sick infants and their parents at Boston Children's Hospital (BCH) or the BWH Neonatal Intensive Care Unit (NICU). A small blood sample will be collected from each infant and genome sequencing may be performed. Six weeks later, results are returned and explained. Over 12 months the investigators are studying the experiences of parents and pediatricians of infants who receive sequencing to help understand how best to use genomics in pediatric care.
Interventions
- GENETIC Genomic sequencing
- OTHER Family history report
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,205 participants |
| Start Date | 2015-05 |
| Est. Completion | 2021-08-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02422511
The ClinicalTrials.gov registry entry for NCT02422511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Genomic sequencing is the first listed.
NCT02422511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02422511 about?
NCT02422511 is a clinical study titled "Genomic Sequencing for Childhood Risk and Newborn Illness". The Genomic Sequencing for Childhood Risk and Newborn Illness (the BabySeq Project) is a research study exploring the use of genomic sequencing in newborns. The National Institutes of Health is funding this study. The investigators will enroll 240 healthy infants and their parents from the Brigham ...
What is the current status of trial NCT02422511?
This trial is currently completed. It is a NA study. The enrollment target is 1,205 participants. The study started on 2015-05. Estimated completion is 2021-08-05.
What interventions are being tested in trial NCT02422511?
The interventions under investigation include: Genomic sequencing (GENETIC), Family history report (OTHER).
Who is sponsoring clinical trial NCT02422511?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.